{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:42:49Z","timestamp":1777714969390,"version":"3.51.4"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Universit\u00e4tsmedizin Essen Clinician Scientist Acedemy"},{"DOI":"10.13039\/100005930","name":"Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005930","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["FU356\/12-1"],"award-info":[{"award-number":["FU356\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["LU2139\/2-1"],"award-info":[{"award-number":["LU2139\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RA969\/12-1"],"award-info":[{"award-number":["RA969\/12-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.pharmthera.2020.107619","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T12:57:34Z","timestamp":1593176254000},"page":"107619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Off-label use of pulmonary vasodilators after left ventricular assist device implantation: Calling in the evidence"],"prefix":"10.1016","volume":"214","author":[{"given":"Maria","family":"Papathanasiou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjang","family":"Ruhparwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Kamler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tienush","family":"Rassaf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Luedike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.pharmthera.2020.107619_bb0005","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1161\/CIRCULATIONAHA.111.058412","article-title":"Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation","volume":"125","author":"Aaronson","year":"2012","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107619_bb0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.healun.2010.06.002","article-title":"Impact of fixed pulmonary hypertension on post\u2013heart transplant outcomes in bridge-to-transplant patients","volume":"29","author":"Alba","year":"2010","journal-title":"The Journal of Heart and Lung Transplantation"},{"issue":"9431","key":"10.1016\/j.pharmthera.2020.107619_bb0015","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(04)16723-8","article-title":"Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the EndothelinA receptor antagonist Trial in heart failure (EARTH): Randomised, double-blind, placebo-controlled trial","volume":"364","author":"Anand","year":"2004","journal-title":"Lancet (London, England)"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0020","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.athoracsur.2012.04.046","article-title":"Inhaled nitric oxide plus iloprost in the setting of post-left assist device right heart dysfunction","volume":"94","author":"Antoniou","year":"2012","journal-title":"The Annals of Thoracic Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0025","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0003-4975(97)01307-6","article-title":"Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension","volume":"65","author":"Argenziano","year":"1998","journal-title":"The Annals of Thoracic Surgery"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0030","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","author":"Armstrong","year":"2020","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0035","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jchf.2017.08.013","article-title":"A Multicenter, randomized, double-blind, placebo-controlled trial of the efficacy and safety of the Oral soluble Guanylate cyclase stimulator: The VICTORIA trial","volume":"6","author":"Armstrong","year":"2018","journal-title":"JACC. Heart Failure"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0040","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/jocs.12214","article-title":"Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence","volume":"28","author":"Atluri","year":"2013","journal-title":"Journal of Cardiac Surgery"},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107619_bb0045","first-page":"888","article-title":"Right heart failure and failure to thrive after left ventricular assist device: Clinical predictors and outcomes","volume":"30","author":"Baumwol","year":"2011","journal-title":"The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2014.04.014","article-title":"Pulmonary hypertension related to left heart disease: Insight from a wireless implantable hemodynamic monitor","volume":"34","author":"Benza","year":"2015","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107619_bb0055","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/CIRCULATIONAHA.113.001458","article-title":"Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: A phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study","volume":"128","author":"Bonderman","year":"2013","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107619_bb0060","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/jocs.12336","article-title":"Incidence, risk, and consequences of atrial arrhythmias in patients with continuous-flow left ventricular assist devices","volume":"29","author":"Brisco","year":"2014","journal-title":"Journal of Cardiac Surgery"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0065","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jacc.2011.06.076","article-title":"Pulmonary pressures and death in heart failure: A community study","volume":"59","author":"Bursi","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0070","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0002-8703(97)70105-4","article-title":"A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan international randomized survival Trial (FIRST)","volume":"134","author":"Califf","year":"1997","journal-title":"American Heart Journal"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.healun.2013.11.005","article-title":"Low cardiac output associated with ventricular tachyarrhythmias in continuous-flow LVAD recipients with a concomitant ICD (LoCo VT study)","volume":"33","author":"Cantillon","year":"2014","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0080","doi-asserted-by":"crossref","first-page":"1), 1","DOI":"10.1016\/j.healun.2005.07.008","article-title":"Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure","volume":"25","author":"Dang","year":"2006","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0085","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.ejheart.2004.10.021","article-title":"Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure","volume":"7","author":"Delgado","year":"2005","journal-title":"European Journal of Heart Failure"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107619_bb0090","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.athoracsur.2007.01.019","article-title":"Medically refractory pulmonary hypertension: Treatment with nonpulsatile left ventricular assist devices","volume":"83","author":"Etz","year":"2007","journal-title":"The Annals of Thoracic Surgery"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107619_bb0095","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.healun.2012.06.002","article-title":"World Health Organization pulmonary hypertension group 2: Pulmonary hypertension due to left heart disease in the adult--a summary statement from the pulmonary hypertension Council of the International Society for heart and lung transplantation","volume":"31","author":"Fang","year":"2012","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.healun.2012.09.013","article-title":"The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: Executive summary","volume":"32","author":"Feldman","year":"2013","journal-title":"Journal of Heart and Lung Transplantation"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107619_bb0105","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1056\/NEJMoa1413687","article-title":"Initial use of Ambrisentan plus Tadalafil in pulmonary arterial hypertension","volume":"373","author":"Gali\u00e8","year":"2015","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension","author":"Gali\u00e8","year":"2016","journal-title":"European Heart Journal."},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0115","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1378\/chest.12-1653","article-title":"Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension","volume":"143","author":"Gerges","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2015.15734","article-title":"Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients withworsening chronic heart failure and reduced ejection fraction the socrates-reduced randomized trial","author":"Gheorghiade","year":"2015","journal-title":"JAMA - Journal of the American Medical Association."},{"issue":"25","key":"10.1016\/j.pharmthera.2020.107619_bb0125","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.CIR.101.25.2922","article-title":"Acute endothelin a receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure","volume":"101","author":"Givertz","year":"2000","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0130","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1053\/j.jvca.2013.05.028","article-title":"Effects of early inhaled epoprostenol therapy on pulmonary artery pressure and blood loss during LVAD placement","volume":"28","author":"Groves","year":"2014","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107619_bb0135","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/j.jacc.2004.09.041","article-title":"The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure","volume":"44","author":"Guazzi","year":"2004","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2005.09.060","article-title":"Sildenafil potentiates nitric oxide mediated inhibition of human platelet aggregation","volume":"337","author":"Gudmundsdottir","year":"2005","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.cardfail.2010.01.003","article-title":"Pulmonary hypertension in heart failure","volume":"16","author":"Guglin","year":"2010","journal-title":"Journal of Cardiac Failure"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0150","first-page":"1","article-title":"Preimplant phosphodiesterase-5 inhibitor use is associated with higher rates of severe early right heart failure after left ventricular assist device implantation an INTERMACS analysis","volume":"12","author":"Gulati","year":"2019","journal-title":"Circulation: Heart Failure"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107619_bb0155","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.mat.0000169125.21268.d7","article-title":"Left ventricular assist devices as bridge to heart transplantation in congestive heart failure with pulmonary hypertension","volume":"51","author":"Haddad","year":"2005","journal-title":"ASAIO Journal"},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107619_bb0160","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cardfail.2015.04.011","article-title":"Inhaled Milrinone after left ventricular assist device implantation","volume":"21","author":"Haglund","year":"2015","journal-title":"Journal of Cardiac Failure"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107619_bb0165","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/S0735-1097(02)02139-3","article-title":"The effect of sildenafil on human vascular function, platelet activation, and myocardial ischemia","volume":"40","author":"Halcox","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1016\/j.pharmthera.2020.107619_bb0170","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/aor.12277","article-title":"Prevention of right heart failure after left ventricular assist device implantation by Phosphodiesterase 5 inhibitor","volume":"38","author":"Hamdan","year":"2014","journal-title":"Artificial Organs"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0175","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0030-1250726","article-title":"Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation","volume":"60","author":"Hefke","year":"2012","journal-title":"The Thoracic and Cardiovascular Surgeon"},{"issue":"7","key":"10.1016\/j.pharmthera.2020.107619_bb0180","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.healun.2016.01.1225","article-title":"Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis","volume":"35","author":"Houston","year":"2016","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"6\u20137","key":"10.1016\/j.pharmthera.2020.107619_bb0185","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.ejheart.2007.01.008","article-title":"Chronic sildenafil lowers transpulmonary gradient and improves cardiac output allowing successful heart transplantation","volume":"9","author":"Jabbour","year":"2007","journal-title":"European Journal of Heart Failure"},{"issue":"2\u20133","key":"10.1016\/j.pharmthera.2020.107619_bb0190","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0167-5273(02)00182-1","article-title":"Do results of the ENABLE (Endothelin antagonist Bosentan for lowering cardiac events in heart failure) study spell the end for non-selective endothelin antagonism in heart failure?","volume":"85","author":"Kalra","year":"2002","journal-title":"International Journal of Cardiology"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s380-002-8320-z","article-title":"Effects of milrinone for right ventricular failure after left ventricular assist device implantation","volume":"16","author":"Kihara","year":"2002","journal-title":"Heart and Vessels."},{"issue":"10","key":"10.1016\/j.pharmthera.2020.107619_bb0200","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth annual INTERMACS report: Special focus on framing the impact of adverse events","volume":"36","author":"Kirklin","year":"2017","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.athoracsur.2006.08.051","article-title":"Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices","volume":"83","author":"Klodell","year":"2007","journal-title":"Annals of Thoracic Surgery"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107619_bb0210","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jtcvs.2009.11.020","article-title":"Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: Incidence, risk factors, and effect on outcomes","volume":"139","author":"Kormos","year":"2010","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107619_bb0215","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jtcvs.2010.08.010","article-title":"Acute impact of left ventricular unloading by left ventricular assist device on the right ventricle geometry and function: Effect of nitric oxide inhalation","volume":"141","author":"Kukucka","year":"2011","journal-title":"Journal of Thoracic and Cardiovascular Surgery"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0220","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ejcts\/ezs678","article-title":"Use of centrifugal left ventricular assist device as a bridge to candidacy in severe heart failure with secondary pulmonary hypertension","volume":"43","author":"Kutty","year":"2013","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"9","key":"10.1016\/j.pharmthera.2020.107619_bb0225","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.healun.2015.06.015","article-title":"Right ventricular failure after left ventricular assist devices","volume":"34","author":"Lampert","year":"2015","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/1755-5922.12111","article-title":"Treatment of secondary pulmonary hypertension with Bosentan after left ventricular assist device implantation","volume":"33","author":"Larue","year":"2015","journal-title":"Cardiovascular Therapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107619_bb0235","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1378\/chest.127.5.1647","article-title":"Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: Combined administration with inhaled nitric oxide","volume":"127","author":"Lepore","year":"2005","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0240","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1161\/CIRCULATIONAHA.106.626226","article-title":"Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure","volume":"115","author":"Lewis","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0245","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.ejcts.2008.12.024","article-title":"Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?","volume":"35","author":"Liden","year":"2009","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"21","key":"10.1016\/j.pharmthera.2020.107619_bb0250","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1161\/01.CIR.0000038497.80095.E1","article-title":"Hemodynamic and Neurohumoral effects of selective Endothelin a (ET A ) receptor blockade in chronic heart failure","volume":"106","author":"L\u00fcscher","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0255","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.ejcts.2004.01.052","article-title":"Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation\u2014A preliminary study1","volume":"25","author":"Martin","year":"2004","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0260","first-page":"2","article-title":"Neurohormonal blockade and Clinical outcomes in patients with heart failure supported by left ventricular assist devices","volume":"5","author":"McCullough","year":"2019","journal-title":"JAMA Cardiology"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0265","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0022-5223(95)70213-X","article-title":"Impact of nitric oxide inhalation on right ventricular failure after implantation of Novacor left ventricular assist system","volume":"109","author":"Mertes","year":"1995","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107619_bb0270","first-page":"971","article-title":"Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients","volume":"40","author":"Mikus","year":"2011","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107619_bb0275","first-page":"290","article-title":"Clinical features, Hemodynamics, and outcomes of pulmonary hypertension due to chronic heart failure with reduced ejection fraction: Pulmonary hypertension and heart failure","volume":"1","author":"Miller","year":"2013","journal-title":"JACC: Heart Failure"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0280","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jacc.2013.09.040","article-title":"Increased need for right ventricular support in patients with chemotherapy-induced cardiomyopathy undergoing mechanical circulatory support: Outcomes from the INTERMACS registry (interagency registry for mechanically assisted circulatory support)","volume":"63","author":"Oliveira","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0285","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.athoracsur.2008.05.016","article-title":"Right heart dysfunction after left ventricular assist device implantation: A comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices","volume":"86","author":"Patel","year":"2008","journal-title":"The Annals of Thoracic Surgery"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5603\/CJ.2012.0027","article-title":"How effective are continuous flow left ventricular assist devices in lowering high pulmonary artery pressures in heart transplant candidates?","volume":"19","author":"Pauwaa","year":"2012","journal-title":"Cardiology Journal"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0295","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","author":"Ponikowski","year":"2016","journal-title":"European Heart Journal."},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107619_bb0300","first-page":"870","article-title":"Inhaled nitric oxide after left ventricular assist device implantation: A prospective, randomized, double-blind, multicenter, placebo-controlled trial","volume":"30","author":"Potapov","year":"2011","journal-title":"Journal of Heart and Lung Transplantation"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0305","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension [5]","author":"Prasad","year":"2000","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0310","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/MAT.0000000000000626","article-title":"Sildenafil in left ventricular assist device is safe and well-tolerated","volume":"64","author":"Ravichandran","year":"2018","journal-title":"ASAIO Journal"},{"issue":"12","key":"10.1016\/j.pharmthera.2020.107619_bb0315","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction","volume":"309","author":"Redfield","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0320","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ccl.2012.03.008","article-title":"Right ventricular failure in patients with left ventricular assist devices","volume":"30","author":"Rich","year":"2012","journal-title":"Cardiology Clinics"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0325","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.healun.2016.08.010","article-title":"The incidence, risk factors, and outcomes associated with late right-sided heart failure in patients supported with an axial-flow left ventricular assist device","volume":"36","author":"Rich","year":"2017","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"5","key":"10.1016\/j.pharmthera.2020.107619_bb0330","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/MAT.0000000000000886","article-title":"Pharmacokinetics of sildenafil in patients with a left ventricular assist device: A word of caution","volume":"65","author":"Sabato","year":"2019","journal-title":"ASAIO Journal (American Society for Artificial Internal Organs: 1992)"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0335","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/0310057X9402200220","article-title":"Inhalation of nitric oxide provides selective pulmonary vasodilatation, aiding mechanical cardiac assist with Thoratec left ventricular assist device","volume":"22","author":"Salamonsen","year":"1994","journal-title":"Anaesthesia and Intensive Care"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0340","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.hlc.2018.04.299","article-title":"Left ventricular assist devices in pulmonary hypertension group 2 with significantly elevated pulmonary vascular resistance: A bridge to cure","volume":"28","author":"Selim","year":"2019","journal-title":"Heart Lung and Circulation"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0345","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1053\/j.jvca.2009.05.002","article-title":"Use of inhaled Epoprostenol in transition to extubation in a patient after implantation of a ventricular assist device","volume":"24","author":"Shapiro","year":"2010","journal-title":"Journal of Cardiothoracic and Vascular Anesthesia"},{"issue":"23","key":"10.1016\/j.pharmthera.2020.107619_bb0350","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/S0735-1097(00)00649-5","article-title":"Acute hemodynamic and neurohumoral effects of selective ET(a) receptor blockade in patients with congestive heart failure","author":"Spieker","year":"2000","journal-title":"Journal of the American College of Cardiology."},{"issue":"8","key":"10.1016\/j.pharmthera.2020.107619_bb0360","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.healun.2015.03.011","article-title":"Incidence and clinical significance of late right heart failure during continuous-flow left ventricular assist device support","volume":"34","author":"Takeda","year":"2015","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"4","key":"10.1016\/j.pharmthera.2020.107619_bb0365","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/CIRCHEARTFAILURE.108.796789","article-title":"PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support","volume":"1","author":"Tedford","year":"2008","journal-title":"Circulation. Heart Failure"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0370","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.healun.2009.05.030","article-title":"Reversal of secondary pulmonary hypertension by axial and pulsatile mechanical circulatory support","volume":"29","author":"Torre-Amione","year":"2010","journal-title":"The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0375","first-page":"208","article-title":"Hemodynamic ramp tests in patients with left ventricular assist devices","volume":"4","author":"Uriel","year":"2016","journal-title":"JACC: Heart Failure"},{"issue":"25 Suppl","key":"10.1016\/j.pharmthera.2020.107619_bb0380","doi-asserted-by":"crossref","first-page":"D100","DOI":"10.1016\/j.jacc.2013.10.033","article-title":"Pulmonary hypertension due to left heart diseases","volume":"62","author":"Vachi\u00e9ry","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/j.pharmthera.2020.107619_bb0385","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01886-2017","article-title":"Macitentan in pulmonary hypertension due to left ventricular dysfunction","author":"Vachi\u00e9ry","year":"2018","journal-title":"European Respiratory Journal."},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0390","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11748-020-01286-6","article-title":"Remote monitoring for better management of LVAD patients: The potential benefits of CardioMEMS","volume":"68","author":"Veenis","year":"2020","journal-title":"General Thoracic and Cardiovascular Surgery"},{"issue":"1","key":"10.1016\/j.pharmthera.2020.107619_bb0395","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/ehf2.12392","article-title":"Design and rationale of haemodynamic guidance with CardioMEMS in patients with a left ventricular assist device: The HEMO-VAD pilot study","volume":"6","author":"Veenis","year":"2019","journal-title":"ESC Heart Failure"},{"issue":"2","key":"10.1016\/j.pharmthera.2020.107619_bb0400","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1213\/01.ANE.0000227219.60581.F2","article-title":"Using inhaled iloprost to wean from cardiopulmonary bypass after implanting a left ventricular assist device","volume":"103","author":"Winterhalter","year":"2006","journal-title":"Anesthesia and Analgesia"},{"issue":"6","key":"10.1016\/j.pharmthera.2020.107619_bb0405","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1525-1594.1995.tb02378.x","article-title":"Inhaled nitric oxide for the management of acute right ventricular failure in patients with a left ventricular assist system","volume":"19","author":"Yahagi","year":"1995","journal-title":"Artificial Organs"},{"issue":"3","key":"10.1016\/j.pharmthera.2020.107619_bb0410","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jtcvs.2006.08.104","article-title":"Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates","volume":"133","author":"Zimpfer","year":"2007","journal-title":"The Journal of Thoracic and Cardiovascular Surgery"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:07:56Z","timestamp":1759010876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820301492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":82,"alternative-id":["S0163725820301492"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107619","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Off-label use of pulmonary vasodilators after left ventricular assist device implantation: Calling in the evidence","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107619"}}